| Application no. and date | 19746141.1 (espacenet) (Federated) (European Patent Register), 20190524 | | Patent/reg. no. and date | DK/EP 3813870, 20231115 | | Publication date | 20210505 | | Priority no. and date | US 201862677114 P, 20180528, US 201962792600 P, 20190115 | | EP pub. no. and date |
EP 3813870 20210505 | | Effective date | | | Applicant/owner | Orion Biotechnology Switzerland Sàrl, Avenue de Sécheron 15
1202 Geneva, CH | | Applicant ref. no. | | | Inventor | HARTLEY, Oliver, 12 chemin Lullin
1256 Troinex, CH,
OFFORD, Robin Ewart, 31 route de Pré-Marais
1233 Bernex, CH | | Representative | | | Opponent | | | IPC Class | A61K 38/18 (2006.01) , A61P 35/00 (2006.01) | | Title | CCR5 INHIBITOR FOR USE IN TREATING CANCER | | Int. application no. | IB2019054350 | | Int. publication no. | WO2019229616 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
